Request for Information (RFI): Developing an STD Federal Action Plan, 19086 [2019-09113]
Download as PDF
19086
Federal Register / Vol. 84, No. 86 / Friday, May 3, 2019 / Notices
www.accessdata.fda.gov/scripts/cder/
daf/.
Dated: April 29, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2019–09005 Filed 5–2–19; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Request for Information (RFI):
Developing an STD Federal Action
Plan
Office of HIV/AIDS and
Infectious Disease Policy, Office of the
Assistant Secretary for Health, Office of
the Secretary, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
To help inform the
development of the Sexually
Transmitted Diseases (STD) Federal
Action Plan, HHS seeks input from
stakeholders on what strategies can be
implemented by federal agencies to
improve the efficiency, effectiveness,
coordination, accountability, and
impact of our national response to
increasing rates of STDs.
DATES: To be assured consideration,
comments must be received at the
address provided below, no later than
5:00 p.m. ET on June 3, 2019.
ADDRESSES: Electronic responses are
strongly preferred and may be addressed
to STDPlan@hhs.gov. Written responses
should be addressed to: U.S.
Department of Health and Human
Services, 330 C Street SW, Room L001,
Washington, DC 20024; Attention STD
RFI.
FOR FURTHER INFORMATION CONTACT:
Melissa Habel, MPH in the HHS Office
of HIV/AIDS and Infectious Disease
Policy, (202) 795–7697.
SUPPLEMENTARY INFORMATION: Rates of
sexually transmitted diseases (STDs) in
2017 reached an all-time high among
males and females and all racial and
ethnic groups. Since 2013, reported
chlamydia rates have increased 22%,
gonorrhea rates 67%, syphilis rates
76%, and congenital syphilis rates
154%; the combined number of cases
was 2.3 million up from 1.8 million in
2013.1 These infections can lead to longterm health consequences such as
infertility and can facilitate HIV
transmission. While gonorrhea,
chlamydia and syphilis infections have
grown considerably over the past four
years, human papillomavirus (HPV)
remains the most commonly sexually
transmitted infection in the U.S.,
amozie on DSK9F9SC42PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:41 May 02, 2019
Jkt 247001
affecting close to half of adults of
reproductive age. HPV infections result
in approximately 33,700 cases of certain
types of cancer each year in the U.S.2
Most of these cancers are preventable
through the use of the HPV vaccination
series. These numbers represent real
people and expose hidden fragile
populations who are not getting the
preventive services and health care they
need. While STDs affect all groups of
the U.S. population, they
disproportionately affect certain
vulnerable groups such as pregnant
women, youth ages 15–24 years, men
who have sex with men, and racial and
ethnic minorities. Beyond the impact on
an individual’s health, in 2013 it was
estimated that STDs cost the U.S. health
care system more than $16 billion
annually, and STDs have increased
dramatically since then.3
To respond and address the STD
public health epidemic, OHAIDP in
collaboration with other federal partners
is leading and coordinating
development of a STD Federal Action
Plan. The development process for the
action plan will seek input from subject
matter experts, nonfederal partners and
stakeholders including health care
providers and systems, state, tribal, and
local health departments, communitybased and faith-based organizations,
national professional organizations,
researchers, advocates, and persons
whose lives have been affected by these
infections. The action plan is expected
to address prevention, diagnosis, care
and treatment, as well as coordination
of efforts, policies, and programs
throughout the federal government. It
will also address stigma, discrimination,
co-infections (e.g., HIV and viral
hepatitis), and social determinants of
health.
This request for information seeks
public input on how the federal
government should address the rising
rates of STDs and what strategies can be
implemented to improve the efficiency,
effectiveness, coordination,
accountability, and impact of the federal
response to STD prevention, care and
treatment policies, services and
programs. The information received will
inform the STD Federal Action Plan.
Topics of interest include but are not
limited to the following:
1. How should the federal government
address the rising rates of STDs?
2. What strategies can be
implemented by federal agencies to
improve the efficiency, effectiveness,
coordination, accountability, and
impact of our national response to
increasing rates of STDs for all priority
populations?
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
3. What are the barriers to people
getting the quality STD health services
they deserve? What strategies can be
implemented by federal agencies to
overcome these barriers?
4. How can federal agencies influence,
design and implement STD-related
policies, services and programs in
innovative and culturally-responsive
ways for priority populations?
5. How can the federal government
help to reduce STD-associated stigma
and discrimination?
Dated: April 11, 2019.
Tammy R. Beckham,
Director, Office of HIV/AIDS and Infectious
Disease Policy.
Footnotes
1. Centers for Disease Control and
Prevention. Sexually Transmitted
Disease Surveillance 2017. Atlanta: U.S:
Department of Health and Human
Services, 2018: Available at https://
www.cdc.gov/std/stats.
2. Eng TR, Butler WT, editors; Institute of
Medicine (US). Summary: The hidden
epidemic: Confronting sexually
transmitted diseases. Washington (DC):
National Academy Press; 1997. p. 43.
3. Owusu-Edusei K Jr, Chesson HW, Gift TL,
et al. The estimated direct medical cost
of selected sexually transmitted
infections in the United States, 2008. Sex
Transm Dis 2013; 40(3):197–201.
DOI:10.1097/OLQ.0b013e318285c6d2.
[FR Doc. 2019–09113 Filed 5–2–19; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[OMHA–1901–N]
Medicare Program; Administrative Law
Judge Hearing Program for Medicare
Claim and Entitlement Appeals;
Quarterly Listing of Program
Issuances—January Through March
2019
Office of Medicare Hearings
and Appeals (OMHA), HHS.
ACTION: Notice.
AGENCY:
This quarterly notice lists the
OMHA Case Processing Manual (OCPM)
instructions that were published from
January through March 2019. This
manual standardizes the day-to-day
procedures for carrying out adjudicative
functions, in accordance with
applicable statutes, regulations, and
OMHA directives, and gives OMHA
staff direction for processing appeals at
the OMHA level of adjudication.
FOR FURTHER INFORMATION CONTACT:
Jason Green, by telephone at (571) 777–
2723, or by email at jason.green@
hhs.gov.
SUMMARY:
E:\FR\FM\03MYN1.SGM
03MYN1
Agencies
[Federal Register Volume 84, Number 86 (Friday, May 3, 2019)]
[Notices]
[Page 19086]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-09113]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Request for Information (RFI): Developing an STD Federal Action
Plan
AGENCY: Office of HIV/AIDS and Infectious Disease Policy, Office of the
Assistant Secretary for Health, Office of the Secretary, Department of
Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: To help inform the development of the Sexually Transmitted
Diseases (STD) Federal Action Plan, HHS seeks input from stakeholders
on what strategies can be implemented by federal agencies to improve
the efficiency, effectiveness, coordination, accountability, and impact
of our national response to increasing rates of STDs.
DATES: To be assured consideration, comments must be received at the
address provided below, no later than 5:00 p.m. ET on June 3, 2019.
ADDRESSES: Electronic responses are strongly preferred and may be
addressed to [email protected]. Written responses should be addressed to:
U.S. Department of Health and Human Services, 330 C Street SW, Room
L001, Washington, DC 20024; Attention STD RFI.
FOR FURTHER INFORMATION CONTACT: Melissa Habel, MPH in the HHS Office
of HIV/AIDS and Infectious Disease Policy, (202) 795-7697.
SUPPLEMENTARY INFORMATION: Rates of sexually transmitted diseases
(STDs) in 2017 reached an all-time high among males and females and all
racial and ethnic groups. Since 2013, reported chlamydia rates have
increased 22%, gonorrhea rates 67%, syphilis rates 76%, and congenital
syphilis rates 154%; the combined number of cases was 2.3 million up
from 1.8 million in 2013.\1\ These infections can lead to long-term
health consequences such as infertility and can facilitate HIV
transmission. While gonorrhea, chlamydia and syphilis infections have
grown considerably over the past four years, human papillomavirus (HPV)
remains the most commonly sexually transmitted infection in the U.S.,
affecting close to half of adults of reproductive age. HPV infections
result in approximately 33,700 cases of certain types of cancer each
year in the U.S.\2\ Most of these cancers are preventable through the
use of the HPV vaccination series. These numbers represent real people
and expose hidden fragile populations who are not getting the
preventive services and health care they need. While STDs affect all
groups of the U.S. population, they disproportionately affect certain
vulnerable groups such as pregnant women, youth ages 15-24 years, men
who have sex with men, and racial and ethnic minorities. Beyond the
impact on an individual's health, in 2013 it was estimated that STDs
cost the U.S. health care system more than $16 billion annually, and
STDs have increased dramatically since then.\3\
To respond and address the STD public health epidemic, OHAIDP in
collaboration with other federal partners is leading and coordinating
development of a STD Federal Action Plan. The development process for
the action plan will seek input from subject matter experts, nonfederal
partners and stakeholders including health care providers and systems,
state, tribal, and local health departments, community-based and faith-
based organizations, national professional organizations, researchers,
advocates, and persons whose lives have been affected by these
infections. The action plan is expected to address prevention,
diagnosis, care and treatment, as well as coordination of efforts,
policies, and programs throughout the federal government. It will also
address stigma, discrimination, co-infections (e.g., HIV and viral
hepatitis), and social determinants of health.
This request for information seeks public input on how the federal
government should address the rising rates of STDs and what strategies
can be implemented to improve the efficiency, effectiveness,
coordination, accountability, and impact of the federal response to STD
prevention, care and treatment policies, services and programs. The
information received will inform the STD Federal Action Plan.
Topics of interest include but are not limited to the following:
1. How should the federal government address the rising rates of
STDs?
2. What strategies can be implemented by federal agencies to
improve the efficiency, effectiveness, coordination, accountability,
and impact of our national response to increasing rates of STDs for all
priority populations?
3. What are the barriers to people getting the quality STD health
services they deserve? What strategies can be implemented by federal
agencies to overcome these barriers?
4. How can federal agencies influence, design and implement STD-
related policies, services and programs in innovative and culturally-
responsive ways for priority populations?
5. How can the federal government help to reduce STD-associated
stigma and discrimination?
Dated: April 11, 2019.
Tammy R. Beckham,
Director, Office of HIV/AIDS and Infectious Disease Policy.
Footnotes
1. Centers for Disease Control and Prevention. Sexually Transmitted
Disease Surveillance 2017. Atlanta: U.S: Department of Health and
Human Services, 2018: Available at https://www.cdc.gov/std/stats.
2. Eng TR, Butler WT, editors; Institute of Medicine (US). Summary:
The hidden epidemic: Confronting sexually transmitted diseases.
Washington (DC): National Academy Press; 1997. p. 43.
3. Owusu-Edusei K Jr, Chesson HW, Gift TL, et al. The estimated
direct medical cost of selected sexually transmitted infections in
the United States, 2008. Sex Transm Dis 2013; 40(3):197-201.
DOI:10.1097/OLQ.0b013e318285c6d2.
[FR Doc. 2019-09113 Filed 5-2-19; 8:45 am]
BILLING CODE P